Table 1.
Demographic and clinical characteristics of patients diagnosed with gastric cancer.
| Characteristic | N = 173 | sHLA-G† | p-value |
|---|---|---|---|
| Gender¶, n (%) | |||
| Male | 119 (68.8) | 13.8 [13.7] | 0.026 |
| Female | 54 (31.2) | 6.44 [12.5] | |
| Age at diagnosis (years) | |||
| Mean ± SD | 59.3 ± 12.9 | ||
| Age group¶, n (%) | |||
| ≤ 60 years | 87 (50.3) | 6.56 [12.6] | 0.168 |
| > 60 years | 86 (49.7) | 9.36 [15.9] | |
| Type of pathology§, n (%) | |||
| Intestinal adenocarcinoma | 101(58.4) | 6.82 [13.7] | 0.419 |
| Signet ring cell adenocarcinoma | 45 (26.0) | 8.04 [15.0] | |
| Other | 27 (15.6) | 12.5 [13.6] | |
| Differentiation degree§, n (%) | |||
| Well-differentiated | 15 (8.70) | 9.68 [10.6] | 0.607 |
| Moderately differentiated | 54 (31.2) | 6.40 [17.3] | |
| Poorly differentiated | 69 (39.9) | 7.20 [11.0] | |
| No data | 35 (20.2) | 12.5 [12.8] | |
| Tumor location§, n (%) | |||
| Pyloric Antrum | 49 (28.3) | 8.91 [17.4] | 0.227 |
| Cardias | 41 (23.7) | 6.36 [11.2] | |
| Body | 73 (42.2) | 9.33 [14.4] | |
| No data | 10 (5.80) | 13.2 [7.72] | |
| Tumor stage§, n (%) | |||
| In situ | 1 (0.60) | 127** | |
| I | 14 (8.10) | 3.35 [6.13] | 0.082 |
| II | 29 (16.8) | 7.85 [16.7] | |
| III | 47 (27.2) | 6.89 [13.5] | |
| IV | 51 (29.4) | 11.2 [13.2] | |
| No data | 31 (17.9) | 12.0 [12.4] | |
| Relapse¶, n (%) | |||
| Yes | 53 (30.6) | 6.90 [14.2] | 0.876 |
| No | 120 (69.4) | 9.06 [14.2] | |
| Vital state¶, n (%) | |||
| Dead | 75 (43.4) | 9.33 [13.9] | 0.361 |
| Alive | 98 (56.6) | 8.18 [13.8] | |
SD Standard deviation.
†Expression level in median [interquartile range].
¶Wilcoxon signed rank testc.
§Kruskal–Wallis test.
**Only one patient presented stage in situ.